Alex Akhiezer's practice focuses on emergent technologies that require a multidisciplinary approach. He works with leading universities, startup companies, venture capital investors, and public companies on technology commercialization, including patent protection and licensing matters as well as patent life cycle management, IP portfolio development and strategies. Alex participates in corporate acquisitions, drafting and negotiating portfolio license agreements, and preparation of opinions to counsel on matters of infringement and validity.
Alex holds an undergraduate degree in Theoretical Physics from Kharkiv University, Ukraine, and a doctorate in Biological and Computational Chemistry from the Massachusetts Institute of Technology. At MIT, his research focused on dissecting protein kinase-mediated signal transduction pathways using small molecules and developing novel structure-based rational drug design methods.
Before beginning his graduate studies, Alex was a scientist in the Protein Chemistry Department at ImClone Systems, Inc. in New York. Alex's research, educational and professional background provides him with a deep understanding of emergent technologies that operate at the intersection of chemistry, biology, and physics, such as:
PHYSICS
CHEMISTRY and LIFE SCIENCES
